Study to Evaluate Laquinimod Compared to Interferon ß-1a Administered by Injection
- Study Title
- A Study to Evaluate 2 Doses Of Oral Administration Of Laquinimod Compared to Interferon ֳŸ-1a Administered by Injection in Participants With Relapsing Remitting Multiple Sclerosis (RRMS)
- Teva Identifier
- LAQ-MS-306 | 2013-002082-19
- ClinicalTrials.gov Identifier
- NCT01975298
- Study Status
- Withdrawn
- Trial Condition(s)
- Relapsing Remitting Multiple Sclerosis
- Interventions
- Drug: Laquinimod | Drug: Avonexֲ®
- Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Adult
- Age Range
- 18 Years to 55 Years
- Trial Duration
- 01/01/2014 - 03/01/2014
- Phase
- Phase 3